Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes

Neuroscience

• Insulin 100%
• Glucose 66%
• Pioglitazone 52%
• Glucose Tolerance Test 38%
• Diabetes 14%
• Research Design 9%
• Hemoglobin A1c 9%
• Placebo 9%
• Cell Function 4%

Nursing and Health Professions

• Glucose Blood Level 57%
• Pioglitazone 52%
• Oral Glucose Tolerance Test 38%
• Insulin Blood Level 28%
• Insulin 19%
• Patient with Type 2 Diabetes 19%
• Glucose 9%
• Area under the Curve 9%
• Hemoglobin A1c 9%
• Placebo 9%
• Procedures 9%
• Dose 9%
• Non Insulin Dependent Diabetes Mellitus 4%
• Clamp 4%

Medicine and Dentistry

• Pioglitazone 52%
• Insulin Sensitivity 42%
• Oral Glucose Tolerance Test 38%
• Inpatient 28%
• Patient 19%
• Glucose 9%
• Glycemic Control 9%
• Hemoglobin A1c 9%
• Dose Response 9%
• Insulin Release 9%
• Man 9%
• Woman 9%
• Maturity Onset Diabetes of the Young 4%
• Cell Function 4%
• Diet 4%